HLA-matched sibling bone marrow transplantation for β-thalassemia major
Open accessThe DOI matches its Crossref record.
Abstract
We describe outcomes after human leukocyte antigen-matched sibling bone marrow transplantation (BMT) for 179 patients with β-thalassemia major. The median age at transplantation was 7 years and the median follow-up was 6 years. The distribution of Pesaro risk class I, II, and III categories was 2%, 42%, and 36%, respectively. The day 30 cumulative incidence of neutrophil recovery and day 100 platelet recovery were 90% and 86%, respectively. Seventeen patients had graft failure, which was fatal in 11. Six of 9 patients with graft failure are alive after a second transplantation. The day 100 probability of acute graft-versus-host disease and 5-year probability of chronic graft-versus-host disease was 38% and 13%, respectively. The 5-year probabilities of overall- and disease-free survival were 91% and 88%, respectively, for patients with Pesaro risk class II, and 64% and 62%, respectively, for Pesaro risk class III. In multivariate analysis, mortality risks were higher in patients 7 years of age and older and those with hepatomegaly before BMT. The leading causes of death were interstitial pneumonitis (n = 7), hemorrhage (n = 8), and veno-occlusive disease (n = 6). Proceeding to BMT in children younger than 7 years before development of end-organ damage, particularly in the liver, should improve results after BMT for β-thalassemia major.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Angelucci, E., Matthes-Martin, S., Baronciani, D., Bernaudin, F., Bonanomi, S., Cappellini, M. D., Dalle, J.-H., Di Bartolomeo, P., de Heredia, C. D., Dickerhoff, R., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.099747 · Cited by 399
Baronciani, D., Angelucci, E., Potschger, U., Gaziev, J., Yesilipek, A., Zecca, M., Orofino, M. G., Giardini, C., Al-Ahmari, A., Marktel, S., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.293 · Cited by 241
Self-citationHematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia
Lucarelli, G., Isgro, A., Sodani, P., & Gaziev, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011825 · Cited by 166
“%) developed chronic GVHD. Class 1 and class 2 patients had much better overall and disease-free survival (96.7% and 80%, respectively) than class 3 patients (65.5% and 54.5%, respectively).”
InfluentialGene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β A(T87Q) - Globin Gene
Negre, O., Eggimann, A.-V., Beuzard, Y., Ribeil, J.-A., Bourget, P., Borwornpinyo, S., Hongeng, S., Hacein-Bey, S., Cavazzana, M., Leboulch, P., et al. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.007 · Cited by 159
Self-citation
Metadata
- Authors
- Sabloff, M., Chandy, M., Wang, Z., Logan, B. R., Ghavamzadeh, A., Li, C.-K., Irfan, S. M., Bredeson, C. N., Cowan, M. J., Gale, R. P., Hale, G. A., Horan, J., Hongeng, S., Eapen, M., & Walters, M. C.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-02-03
- Volume
- 117
- Issue
- 5
- Pages
- 1745-1750
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2031359173
- Cited by
- 133
- References
- 0
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HLA-matched sibling bone marrow transplantation for β-thalassemia major. https://app.cochat.ai/papers/10.1182/blood-2010-09-306829
- The paper
- Sabloff, M., Chandy, M., Wang, Z., Logan, B. R., Ghavamzadeh, A., Li, C.-K., Irfan, S. M., Bredeson, C. N., Cowan, M. J., Gale, R. P., Hale, G. A., Horan, J., Hongeng, S., Eapen, M., & Walters, M. C. (2011). HLA-matched sibling bone marrow transplantation for β-thalassemia major. Blood. https://doi.org/10.1182/blood-2010-09-306829
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.